Back to Search Start Over

Association of APOE Genotypes and Chronic Traumatic Encephalopathy

Authors :
Kathryn Atherton
Xudong Han
Jaeyoon Chung
Jonathan D. Cherry
Zachary Baucom
Nicole Saltiel
Evan Nair
Bobak Abdolmohammadi
Madeline Uretsky
Mohammed Muzamil Khan
Conor Shea
Shruti Durape
Brett M. Martin
Joseph N. Palmisano
Kurt Farrell
Christopher J. Nowinski
Victor E. Alvarez
Brigid Dwyer
Daniel H. Daneshvar
Douglas I. Katz
Lee E. Goldstein
Robert C. Cantu
Neil W. Kowall
Michael L. Alosco
Bertrand R. Huber
Yorghos Tripodis
John F. Crary
Lindsay Farrer
Robert A. Stern
Thor D. Stein
Ann C. McKee
Jesse Mez
Source :
JAMA Neurol
Publication Year :
2022

Abstract

ImportanceRepetitive head impact (RHI) exposure is the chief risk factor for chronic traumatic encephalopathy (CTE). However, the occurrence and severity of CTE varies widely among those with similar RHI exposure. Limited evidence suggests that the APOEε4 allele may confer risk for CTE, but previous studies were small with limited scope.ObjectiveTo test the association between APOE genotype and CTE neuropathology and related endophenotypes.Design, Setting, and ParticipantsThis cross-sectional genetic association study analyzed brain donors from February 2008 to August 2019 from the Veterans Affairs–Boston University–Concussion Legacy Foundation Brain Bank. All donors had exposure to RHI from contact sports or military service. All eligible donors were included. Analysis took place between June 2020 and April 2022.ExposuresOne or more APOEε4 or APOEε2 alleles.Main Outcomes and MeasuresCTE neuropathological status, CTE stage (0-IV), semiquantitative phosphorylated tau (p-tau) burden in 11 brain regions (0-3), quantitative p-tau burden in the dorsolateral frontal lobe (log-transformed AT8+ pixel count per mm2), and dementia.ResultsOf 364 consecutive brain donors (100% male; 53 [14.6%] self-identified as Black and 311 [85.4%] as White; median [IQR] age, 65 [47-77] years) 20 years or older, there were 294 individuals with CTE and 70 controls. Among donors older than 65 years, APOEε4 status was significantly associated with CTE stage (odds ratio [OR], 2.34 [95% CI, 1.30-4.20]; false discovery rate [FDR]–corrected P = .01) and quantitative p-tau burden in the dorsolateral frontal lobe (β, 1.39 [95% CI, 0.83-1.94]; FDR-corrected P = 2.37 × 10−5). There was a nonsignificant association between APOEε4 status and dementia (OR, 2.64 [95% CI, 1.06-6.61]; FDR-corrected P = .08). Across 11 brain regions, significant associations were observed for semiquantitative p-tau burden in the frontal and parietal cortices, amygdala, and entorhinal cortex (OR range, 2.45-3.26). Among football players, the APOEε4 association size for CTE stage was similar to playing more than 7 years of football. Associations were significantly larger in the older half of the sample. There was no significant association for CTE status. Association sizes were similar when donors with an Alzheimer disease neuropathological diagnosis were excluded and were reduced but remained significant after adjusting for neuritic and diffuse amyloid plaques. No associations were observed for APOEε2 status. Models were adjusted for age at death and race.Conclusions and RelevanceAPOEε4 may confer increased risk for CTE-related neuropathological and clinical outcomes among older individuals with RHI exposure. Further work is required to validate these findings in an independent sample.

Details

ISSN :
21686157
Volume :
79
Issue :
8
Database :
OpenAIRE
Journal :
JAMA neurology
Accession number :
edsair.doi.dedup.....a15e4d76f50ea5b321d8e49d6aacb144